This PDF file includes:
Supplementary text -Materials and Methods Supplementary figures Fig. S1 . Western blot for p53ER TAM and ARF expression in Eµ-Myc lymphomas. Fig. S2 . p53 reactivation response in multiple independent late-OFF and a p53-/-Eµ-Myc lymphoma. Fig. S3 . Deletion of Cdkn2a gene locus in TAM-resistant Eµ-Myc lymphomas. Fig. S4 . Lack of Cdkn2a methylation in p53-ON lymphomas. Fig. S5 . Polycomb group protein-mediated repression of Cdkn2a locus is reduced upon late p53 inactivation. Fig. S6 . Mdm2 inhibition sensitizes human ARF-deficient p53ER TAM tumor cells to p53 reactivation. References for SI reference citations 480 (Roche). Expression data were normalized against β-actin. For RNAseq, RNA quality was assessed using the Experion RNA StdSens Analysis Kit (BioRad). RNAseq libraries were prepared from total RNA using the TruSeq Stranded mRNA LT kit (Illumina) according to the manufacturer's instructions. Quality of sequencing libraries was controlled on a Bioanalyzer 2100 using the Agilent High Sensitivity DNA Kit (Agilent). Pooled sequencing libraries were quantified with digital PCR (QuantStudio 3D, Thermo Fisher) and sequenced on the HiSeq 1500 platform (Illumina) in Rapid-Run mode with 50 bases single reads. Obtained sequencing data were aligned to the Ensembl Mus musculus reference genome, revision 92 (mm10) using STAR and read counts were obtained for exonic regions. Genes with less than 10 reads in all samples were pruned from the count table. Subsequently, differential expression was assessed using DEseq2 (5) and false discovery rate was controlled via Benjamini-Hochberg correction. Sequencing data were deposited at EBI ArrayExpress (accession number E-MTAB-8015).
Primer sequences for RT-qPCR:
CAAGAGGCCCAGTACTTCCT ACACCAGAGTGCAAGACAGC Analysis for genomic Cdkn2a deletion. Genomic DNA was isolated from primary lymphoma tissues or in vitro cultured cell lines with peqGOLD Tissue DNA Kit (PeqLab) and used as template for qPCR with primers mapping to different regions of the Cdkn2a gene locus or a reference region 50 kb upstream. DCt values were used as a measure for Cdkn2a deletion.
Primer sequences: pair #  sense  antisense  1  CTTTCGCTCCGGTTAACTTTC  CCTCGCCGATCTTCCTATTT  2  AGTGCTGGGACTAAAGGGATTTG CACCATTAAGGAGGACGCCTAG  3  CAGCTGCTCTTCTTCCTCTCC  AGAATACAGCAGGATCAGGTACG  4  GCTGACAGTAGATGGGAGAAAC  GGAGCCACCCATTAAACTAACT  5  GGGACATCAAGACATCGTGC  GTTCCCAGCGGTACACAAAG  6 CAATCCCAAGAGCAGAGCTAAATC TTAAAGCCACATGCTAGACACG Cdkn2a-50kb GGTGCTAGTGAGGGCTTGGC ACATTTCCCTACCGCCGCTG Cdkn2a methylation analysis. Genomic DNA isolated from lymphoma tissues was subjected to bisulfite conversion with EpiTect Bisulfite Kit (Qiagen) according to the manufacturer's protocol. To control conversion efficacy, 1 µg of genomic DNA was methylated in vitro in the presence of 4 IU of CpG Methyltransferase M.SssI (NEB) and 1.6 mM S-adenosylmethionine for 1 h at 37°C, purified by phenol-chloroform extraction and used for bisulfite conversion. Primers for amplification of converted DNA were designed using MethPrimer software (6) . Converted DNA was amplified with primers GTTTTTGGTTATTGTGAGGATTTAG and AACCTTTCCTACCTAATCCAAAATT and cloned into the pCR2.1 vector using TOPO-TA Cloning Kit (Thermo Fisher). Single plasmid clones were analyzed by Sanger sequencing (LGC).
Chromatin immunoprecipitation. For chromatin preparation, 50-200 mg of fresh-frozen lymphoma tissues (lymph nodes) were transferred in tissueTUBE TT1 (Covaris), submerged in liquid nitrogen for 10 s and then pulverized with a hammer. Pulverized tissue was resuspended in 10 ml of PBS supplemented with protease inhibitors (cOmplete ULTRA Tablets Mini, Roche) and crosslinked by addition of 0.5 ml of 18.5% paraformaldehyde (10 min, RT). After incubation for 5 min, 1 ml of 1.25 M glycine was added and after 5 min incubation samples were centrifuged. The supernatant was discarded and the pellets were frozen. Pellets were then lysed in SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris pH 8.1) supplemented with protease inhibitor (1.6 ml buffer/70 mg tissue). Samples were then sonicated using Bioruptor® (Diagenode) (5 cycles of 30 sec "ON" and 30 sec "OFF"). After centrifugation, 100 µl sheared chromatin was diluted 1:10 with dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl) and pre-cleared for 1 h with Protein G Sepharose™ 4 Fast Flow (GE Healthcare) at 4°C. Afterwards, 1% input was sampled. Proteins were precipitated with 2.5 µg antibody for H3K27me3 (Merck-Millipore, 07-449), H2AK119ub (Cell Signaling, D27C4) and normal rabbit IgG (Cell Signaling, 2729) overnight at 4°C. Next day, 50 µl of beads pre-blocked in 0.5% BSA were added and samples were incubated 4 h at 4°C. Beads were pelleted and washed once with low salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 150 mM NaCl), once with high salt wash buffer (0.1% SDS, 1%Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM NaCl), once with LiCl wash buffer (0.25 M LiCl, 1% IGEPAL-CA630, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 8.1), and twice with TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). DNA was de-crosslinked from proteins by adding 100 µl of 10% Chelex suspension to ChIP and input samples, 10 min incubation at 99°C followed by proteinase K digestion for 30 min at 55°C and inactivation of proteinase K at 99°C for 10 min. Precipitated DNA was recovered by two rounds of elution with 2x100 µl sterile water. DNA was further diluted 1:2 with water. 3 µl DNA were used as a template for qPCR. The abundance of each modification was calculated as % input. . Animals were anesthetized with 2% isoflurane and imaged 5 min after injection with IVIS 50 system (Xenogen) for 30 seconds. Primary FLC recipients were euthanized by cervical dislocation when reaching the humane endpoint specified by the experimental protocol. Lymphoma cells were isolated from lymph nodes and spleens and used for establishment of cell lines or further propagation by serial transplantation.
For reactivation experiments, cohorts of B6-albino mice were intravenously transplanted with lymphoma cells, fed with normal chow and monitored by BLI. Animals were treated for 7 days with daily i.p. injections of tamoxifen (100 µl of 10 mg/ml solution in corn oil) or vehicle. Treatment started 4 days after transplantation (Fig. 2G ) or once bioluminescence was clearly detectable in spleen and cervical lymph nodes ( Fig. 2E,F) . All animal experiments were performed according to the German Animal Welfare Act and approved by the Regional Board Giessen.
Statistical analysis.
For animal experiments, an a priori power analysis was performed to calculate the group size needed to measure an estimated effect size (Cohen's d) of 1.0 with sufficient statistical power (a=0.05, 1-b=0.80). GraphPad Prism 8 Software was used to generate all plots and perform statistical analysis. False discovery rates were calculated with the two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli (8) . P or FDRq values <0.05 were considered significant. 
